
CONGEN produces 10+ million tests for the detection of SARS-CoV-2
At the beginning of 2020, CONGEN was one of the first German companies to develop a molecular biological test for the detection of SARS-CoV-2. The continuously increasing demand for PCR tests is being met by CONGEN with great effort and engagement. The CE certified test is characterized by a high level of specificity and sensitivity, […]